ASLAN inlicenses preclinical candidate drugs
and takes them to proof-of-concept, leveraging high quality resources in
Asia, then offers them back to the originator or other pharma companies for
late phase global development.
ASLAN is currently looking to inlicense
preclinical and early development compounds into our pipeline across a
variety of therapeutic areas